Prograf Alternatives Compared
| Prograf (tacrolimus) | Tacrolimus | CellCept (mycophenolate mofetil) |
|
|---|
| Prograf (tacrolimus) | Tacrolimus | CellCept (mycophenolate mofetil) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Organ Transplant - Rejection Reversal, Organ Transplant - Rejection Prophylaxis. Prograf may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Organ Transplant - Rejection Reversal, Nephrotic Syndrome, Organ Transplant - Rejection Prophylaxis, Graft Versus Host Disease, Crohn's Disease. Tacrolimus may also be used for... View more |
Prescription only
Prescribed for Organ Transplant - Rejection Prophylaxis. CellCept may also be used for purposes not listed in this medication guide. |
Related suggestions Organ Transplant, Rejection Prophylaxis
Popular comparisons
|
|||||||||||||||||||||||
| More about Prograf (tacrolimus) | More about Tacrolimus | More about CellCept (mycophenolate mofetil) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Prograf has an average rating of 8.1 out of 10 from a total of 28 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 7% reported a negative effect. |
Tacrolimus has an average rating of 7.9 out of 10 from a total of 49 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 12% reported a negative effect. |
CellCept has an average rating of 8.3 out of 10 from a total of 35 ratings on Drugs.com. 77% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Prograf side effects |
View all Tacrolimus side effects |
View all CellCept side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Prograf prices |
View all Tacrolimus prices |
View all CellCept prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other tacrolimus brands include: Astagraf XL, Envarsus XR | Astagraf XL, Envarsus XR, Prograf | Other mycophenolate mofetil brands include: Myhibbin | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
21.2 hours |
21.2 hours |
18 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 864 drugs are known to interact with Prograf:
|
A total of 864 drugs are known to interact with Tacrolimus:
|
A total of 342 drugs are known to interact with CellCept:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 08, 1994 |
April 08, 1994 |
May 03, 1995 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.